Key takeaways:
Patients with GI cancer who do not identify as white, have advanced disease or had recent treatment may have worse financial toxicity.
Financial toxicity was associated with reduced medication use due to cost.
The most “vulnerable” individuals with gastrointestinal cancer can also experience the worst financial toxicity.
In a study of more than 8,000 patients, greater than 40% experienced financial toxicity and close to 30% reported at least one health-related social risk, including issues with food, housing or transportation.
Data derived from Narayan A, et al. JCO Oncol Pract . 2025;doi:10.1200/OP-25-00218.
Race, advanced disease and recent treatments all had significant associations with both.
Worse financial toxicity also had significant associations with re